Moreover, the oncogene Ras was usually demonstrated to be constitutively activated in LC through Ras or EGFR (EGF receptor) mutations, playing an important role in LC development, mainly via TGF-β [16,18]. The gene discussed is TGFB1; the disease is laryngotracheoesophageal cleft.